FDA Adverse Event Malfunction Summary report: N

PLUM XLM W/DATAPORT

MDR report key: 3874263 · Received April 18, 2014

Report

Report Number
9615050-2014-02770
Event Type
Malfunction
Date Received
April 18, 2014
Date of Event
January 1, 2013
Report Date
May 11, 2013
Manufacturer
HOSPIRA COSTA RICA LTD.
Product Code
FRN
PMA / PMN Number
K010924
Removal / Correction Number
NA
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
CO
Reporter Occupation
OTHER

Narratives

Additional Manufacturer Narrative · 1

A FIELD SERVICE ENGINEER PERFORMED TESTING AT THE USER FACILITY. DURING TESTING, IT WAS NOTED THAT THE DEVICE DOOR ROLLER PIN WAS BROKEN. THE DEVICE DOOR COULD NOT BE PROPERLY CLOSED DUE TO THE BROKEN DOOR ROLLER PIN. WHEN THE DEVICE DOOR IS NOT PROPERLY CLOSED, THE CASSETTE REGULATOR WILL BE OPENED AND THE VALVES WILL NOT BE CLOSED PROPERLY WHEN THE DEVICE DOOR IS CLOSED. THE VALVES MUST BE CLOSED BY THE DEVICE MECHANISM VALVE PINS IN ORDER TO PREVENT FLUID FROM FLOWING FREELY THROUGH THE CASSETTE. THE PROBABLE CAUSE FOR THE BROKEN DEVICE DOOR ROLLER PIN WAS LEAVING THE DEVICE DOOR ASSEMBLY IN THE OPEN POSITION EXPOSING THE DEVICE DOOR ROLLER PIN TO CONTACT DAMAGE. THIS REPORT IS BEING MADE AS PART OF A RETROSPECTIVE REVIEW. THIS REPORT REPRESENTS ALL THE INFORMATION KNOWN BY THE REPORTER UPON QUERY BY HOSPIRA PERSONNEL.

Description of Event or Problem · 1

DURING TESTING AT THE USER FACILITY, IT WAS NOTED THAT THE DEVICE DOOR ROLLER PIN WAS BROKEN. THE DEVICE WAS RETURNED TO THE BIOMEDICAL DEPARTMENT WITH AN UNSIGNED NOTE THAT INDICATED DAMAGED, NO FUNCTION. NO TRACKING INFORMATION WAS PROVIDED; THEREFORE, SPECIFIC PATIENT INFORMATION, PUMP PROGRAMMING, OR EVENT DETAILS WERE NOT AVAILABLE. THERE WERE NO REPORTS OF ANY ADVERSE PATIENT EVENTS OR DELAYS IN CRITICAL THERAPIES WHILE THE DEVICE WAS IN CLINICAL USE. NO ADDITIONAL INFORMATION WAS PROVIDED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
238065 PLUM XLM W/DATAPORT 80FRN FRN HOSPIRA COSTA RICA LTD. NA NA

Patients

Seq Age Sex Outcome Treatment
1 UNK